NASDAQ · NDAQ
Nasdaq, Inc.
$105.60+$0.05 (+0.05%)
Nasdaq, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.16% below the high.
Loading market information…
NYSE · RELX · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
RELX Plc’s quoted price sits in the upper half of its reported 52-week range, 12.61% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
RELX Plc’s forward annual dividend is $0.56 per share, paid semi-annual. The forward yield is 1.44% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
RELX Plc’s next earnings report is currently expected on Feb 18, 2027, with estimated earnings per share of $0.91. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow RELX Plc’s reporting calendar.
THE COMPANY BEHIND THE TICKER
RELX Plc is a global enterprise that delivers data-driven analytical solutions and strategic decision-making instruments to professional and corporate clients across North America, Europe, and other international markets. Its operations are structured into four distinct divisions: Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions. The Risk division specializes in providing advanced analytical platforms and decision support systems. These tools leverage a blend of publicly available and industry-specific data, integrated with sophisticated technology and algorithms, to help clients assess and forecast potential risks. Through its Scientific, Technical & Medical unit, RELX furnishes crucial information and analytical insights designed to foster scientific advancement and improve healthcare outcomes for institutions and practitioners alike. The Legal sector provides comprehensive legal, regulatory, and commercial intelligence, alongside analytical capabilities, enabling clients to make informed choices and enhance their operational efficiency. Finally, the Exhibitions division manages a portfolio of events, merging in-person interactions with data-driven and digital resources. This approach assists attendees in exploring market trends, identifying products, and facilitating business transactions. Established in 1903, the company, originally named Reed Elsevier PLC, adopted its current identity, RELX PLC, in July 2015. Its global headquarters are situated in London, United Kingdom.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:24 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| $5.98B-2.34% vs estimate |
| Q2 2023 | Jul 27, 2023 | $0.72+4.79% vs estimate | $5.78B+1.14% vs estimate |
|---|
| Q4 2022 | Feb 16, 2023 | $0.66-0.9% vs estimate | $5.51B+1.63% vs estimate |
|---|
THE ANALYST VIEW
7 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$105.60+$0.05 (+0.05%)
Nasdaq, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.16% below the high.
$116.35+$0.26 (+0.22%)
Thomson Reuters Corporation’s quoted price sits in the lower half of its reported 52-week range, 27.37% below the high.
$618.55+$13.61 (+2.25%)
MSCI Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.07% below the high.
$190.71+$0.91 (+0.48%)
Verisk Analytics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 16.05% below the high.
€84.70+€0.90 (+1.07%)
Wolters Kluwer N.V.’s quoted price sits in the upper half of its reported 52-week range, 23.87% below the high.
$75.46+$3.06 (+4.23%)
UL Solutions Inc.’s quoted price sits in the lower half of its reported 52-week range, 29.83% below the high.
£8.30+£0.02 (+0.29%)
Informa plc’s quoted price sits in the lower half of its reported 52-week range, 17.04% below the high.
CA$57.06+CA$0.30 (+0.53%)
TMX Group Limited’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
